Last week, an article by Barbara Bridgman Perkins, PhD, was published in the Washington Post admonishing the relationships between industry and health care providers to advance radiotherapy treatment. Here is what I submitted in response.
Top News
Blog Post | October 11, 2018
Press Release | October 8, 2018
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Matthew Wetzel, vice president and assistant general counsel, regarding this week’s filing of an amicus curiae brief with the Utah Supreme Court in the case of Burningham v. Wright Medical:
Press Release | October 1, 2018
Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Mexico-Canada Agreement (USMCA):
Events
October
23
October 23, 2018 to October 24, 2018
| Washington, DC Whether you have recently taken on compliance responsibilities, are about to set up a new compliance structure, are in the midst of revamping your existing program, or you simply need a refresher,... Read More
October
24
October 24, 2018 to October 25, 2018
| Washington, DC Those who manage healthcare compliance in medical device companies know that their work involves many complexities and that absolute issue resolutions can be elusive. This advanced program will... Read More
October
25
October 25, 2018 |
Have you encountered problems navigating the worlds of coverage and coding? Have you asked yourself what code do I use, or do I need a code? Do you find yourself struggling with the distinction... Read More
October
30
October 30, 2018 | Virtual
As they say, it’s a wide, wide world out there. This is especially true for regulatory affairs (RA) professionals in charge of the registration of medical devices throughout the world. Countries and... Read More
November
06
November 6, 2018 to November 7, 2018
| Washington, DC VIEW THE AGENDA HERE
From products to consumers to regulation and new media—we’re gathering industry practitioners to take a deep dive on the opportunities and challenges of product advertising. This... Read More
Featured Video
The medical technology industry is committed to safety, effectiveness and quality for all devices. Companies employ scientists, physicians, engineers, quality experts and other professionals to research and examine every aspect of a medical device to ensure that it performs as intended.
Industry News
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...
Helius Medical Technologies, Inc.
NEWTOWN, PA., April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions. The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
Twitter Feed
October 19, 2018 - 4:00pm
We’re rooting for Owlet in the Extreme Tech Challenge! Their flagship medtech device empowers parents with real-tim… https://t.co/nWzOaf3lPJ
October 19, 2018 - 3:01pm
More and more cancer patients are relying on radiotherapy. It’s time for the UK to invest in better access to this… https://t.co/sLLc2xGlEt